• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Do not stop effective atrial-based antitachycardia pacing: Insights into episode duration and success rate for termination.

作者信息

Yanagisawa Satoshi, Sato Yuki, Shimizu Atsuya, Narita Yuji, Inden Yasuya, Murohara Toyoaki

机构信息

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Advanced Cardiovascular Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

HeartRhythm Case Rep. 2024 Aug 16;10(12):867-871. doi: 10.1016/j.hrcr.2024.08.016. eCollection 2024 Dec.

DOI:10.1016/j.hrcr.2024.08.016
PMID:39897697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11781891/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b02/11781891/584ec6869b9a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b02/11781891/5bc159e98bfa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b02/11781891/2747b5397a4d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b02/11781891/584ec6869b9a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b02/11781891/5bc159e98bfa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b02/11781891/2747b5397a4d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b02/11781891/584ec6869b9a/gr3.jpg

相似文献

1
Do not stop effective atrial-based antitachycardia pacing: Insights into episode duration and success rate for termination.不要停止有效的基于心房的抗心动过速起搏：对发作持续时间和终止成功率的见解。
HeartRhythm Case Rep. 2024 Aug 16;10(12):867-871. doi: 10.1016/j.hrcr.2024.08.016. eCollection 2024 Dec.
2
Atrial fibrillation induced by appropriate ventricular antitachycardia pacing in an ICD recipient.植入式心脏复律除颤器（ICD）患者中，适当的心室抗心动过速起搏诱发的心房颤动。
J Cardiol Cases. 2020 May 13;22(2):94-96. doi: 10.1016/j.jccase.2020.04.009. eCollection 2020 Aug.
3
Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial.心房抗心动过速起搏与心房重构：MINERVA 国际随机试验的子研究。
Heart Rhythm. 2017 Oct;14(10):1476-1484. doi: 10.1016/j.hrthm.2017.05.023. Epub 2017 May 12.
4
New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.新一代心房抗心动过速起搏（反应性 ATP）与心动过缓患者持续性或永久性心房颤动风险降低相关：MINERVA 随机多中心国际试验的结果。
Heart Rhythm. 2015 Aug;12(8):1717-25. doi: 10.1016/j.hrthm.2015.04.015. Epub 2015 Apr 11.
5
[Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination].抗心动过速起搏器对房性快速性心律失常检测、预防及终止的作用
Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Apr;34(4):333-7.
6
Characteristics of successful termination of atrial fibrillation by atrial antitachycardia pacing in patients with cardiac implantable electronic devices.心脏植入式电子设备患者心房抗心动过速起搏成功终止心房颤动的特征。
Heart Vessels. 2024 Oct;39(10):884-890. doi: 10.1007/s00380-024-02409-2. Epub 2024 Apr 28.
7
Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease.先天性心脏病修复术后心房抗心动过速起搏的益处与潜在风险
Pacing Clin Electrophysiol. 1995 May;18(5 Pt 1):1005-16. doi: 10.1111/j.1540-8159.1995.tb04741.x.
8
Dual chamber pacing mode in an atrial antitachycardia pacing device without a ventricular lead - A necessary evil.
Indian Pacing Electrophysiol J. 2015 Jul 29;15(2):133-7. doi: 10.1016/j.ipej.2015.07.012. eCollection 2015 Mar-Apr.
9
Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: randomised study comparing subthreshold and nominal pacing outputs.心房除颤器患者中行心房抗心动过速起搏治疗的效果：比较亚阈值和标称起搏输出的随机研究
Heart. 2002 May;87(5):433-7. doi: 10.1136/heart.87.5.433.
10
Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome.高位房间隔起搏与反应性心房抗心动过速起搏联合应用对病态窦房结综合征患者房颤的预防作用
J Arrhythm. 2023 Jun 26;39(4):566-573. doi: 10.1002/joa3.12888. eCollection 2023 Aug.

本文引用的文献

1
Characteristics of successful termination of atrial fibrillation by atrial antitachycardia pacing in patients with cardiac implantable electronic devices.心脏植入式电子设备患者心房抗心动过速起搏成功终止心房颤动的特征。
Heart Vessels. 2024 Oct;39(10):884-890. doi: 10.1007/s00380-024-02409-2. Epub 2024 Apr 28.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南：心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
3
Atrial fibrillation induced by inappropriate reactive antitachycardia pacing due to far field R wave oversensing: A case report.因远场R波感知过度导致不适当反应性抗心动过速起搏诱发的心房颤动：一例报告
J Cardiol Cases. 2023 Mar 6;28(1):16-20. doi: 10.1016/j.jccase.2023.02.022. eCollection 2023 Jul.
4
Characteristics of successful reactive atrial-based antitachycardia pacing in patients with cardiac implantable electronic devices: History of catheter ablation of atrial fibrillation as a predictor of high treatment efficacy.心脏植入式电子设备患者成功的反应性基于心房的抗心动过速起搏的特征：房颤导管消融史作为高治疗效果的预测因子。
J Cardiovasc Electrophysiol. 2022 Jul;33(7):1515-1528. doi: 10.1111/jce.15551. Epub 2022 May 27.
5
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.连续监测评估的冷冻球囊或射频消融治疗心房颤动：一项随机临床试验。
Circulation. 2019 Nov 26;140(22):1779-1788. doi: 10.1161/CIRCULATIONAHA.119.042622. Epub 2019 Oct 21.
6
New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.新一代心房抗心动过速起搏（反应性 ATP）与心动过缓患者持续性或永久性心房颤动风险降低相关：MINERVA 随机多中心国际试验的结果。
Heart Rhythm. 2015 Aug;12(8):1717-25. doi: 10.1016/j.hrthm.2015.04.015. Epub 2015 Apr 11.
7
Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.强化起搏模式对心动过缓患者医疗资源利用及成本的影响：随机MINERVA试验分析
Heart Rhythm. 2015 Jun;12(6):1192-200. doi: 10.1016/j.hrthm.2015.02.017. Epub 2015 Feb 19.
8
Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.阵发性或持续性房性快速性心律失常的心动过缓患者的心房抗心动过速起搏和心室按需起搏：MINERVA随机多中心国际试验
Eur Heart J. 2014 Sep 14;35(35):2352-62. doi: 10.1093/eurheartj/ehu165. Epub 2014 Apr 25.
9
The role of pacing mode in the development of atrial fibrillation.
Europace. 2006 Feb;8(2):89-95. doi: 10.1093/europace/euj038. Epub 2006 Jan 16.
10
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.房颤引发房颤。一项对长期植入仪器的清醒山羊的研究。
Circulation. 1995 Oct 1;92(7):1954-68. doi: 10.1161/01.cir.92.7.1954.